FDA Adverse Event Injury Summary report: N

DUROM ACETABULAR COMPONENT 52/46 CODE L

MDR report key: 2243788 · Received August 30, 2011

Report

Report Number
9613350-2011-00572
Event Type
Injury
Date Received
August 30, 2011
Date of Event
January 4, 2011
Report Date
August 10, 2011
Manufacturer
ZIMMER, INC.
Product Code
KWA
Removal / Correction Number
Z-2415/2426-2008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE MFR DID NOT RECEIVE EXPLANTED DEVICES OR X-RAYS FOR REVIEW. WHERE LOT NUMBERS WERE RECEIVED FOR THE EXPLANTED DEVICES, THE DEVICE HISTORY RECORDS WERE REVIEWED AND FOUND TO BE CONFORMING. BASED ON AN EXTENSIVE INVESTIGATION OF EVENTS REPORTED FROM SEVERAL USERS FACILITIES OUTSIDE THE UNITED STATES, ZIMMER IDENTIFIED THAT THE MOST PROBABLE CAUSE FOR THE OUTCOME OBSERVED WAS A LOOSE OR UNSTABLE CUP THAT RESULTED FROM USE OF SURGICAL TECHNIQUES NOT CONSISTENT WITH THE MANUFACTURER'S RECOMMENDATIONS. AS A CORRECTIVE ACTION, A RETRAINING PROGRAM FOR USERS OUTSIDE THE UNITED STATES WAS INITIATED IN NOVEMBER 2009 AND REPORTED TO THE NATIONAL COMPETENT AUTHORITIES AS REQUIRED. THE DUROM CUP REPORTED IN THIS CASE IS NOT MARKETED IN THE UNITED STATES. A SIMILAR CUP, COMPATIBLE WITH THE METASUL LDH FEMORAL HEAD, IS CLEARED IN THE UNITED STATES AND A CORRECTIVE ACTION FOR THIS PRODUCT WAS REPORTED TO THE FDA IN JULY 2008 AS CORRECTION Z-2415/2426-2008. SHOULD ADDITIONAL INFO INCLUDING THE FINAL INVESTIGATION RESULT BE AVAILABLE, THAT CHANGES THIS ASSESSMENT, AN AMENDED MEDICAL DEVICE REPORT WILL BE FILED. THE NEED FOR FURTHER CORRECTIVE MEASURES IS NOT INDICATED AT THIS TIME AND ZIMMER (B)(4) CONSIDERS THIS CASE AS CLOSED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PT HAD NEVER FELT RIGHT AND LIMPING WAS ALWAYS A PROBLEM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DUROM ACETABULAR COMPONENT 52/46 CODE L DUROM ACETABULAR COMPONENT AND METASUL KWA ZIMMER, INC. 2388411

Patients

Seq Age Sex Outcome Treatment
1 50 YR Hospitalization| R